Fintel reports that on March 5, 2025, Citigroup upgraded their outlook for ResMed (NYSE:RMD) from Neutral to Buy. Analyst ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report). The ...

Sabra Health Care REIT, Inc. (Nasdaq ... the company’s Executive Vice President of Finance, will attend Citi’s 2025 Global Property CEO Conference on March 3-5, 2025 at The Diplomat Beach ...

Citigroup Inc. upgraded Indian stocks to overweight from neutral, while turning underweight on equities in Southeast Asia.

The Nifty index fell 1% to 22,574 on Monday, the lowest since June 2024. For Citi, financials and health-care are among key ...